Rectangle Pattern Suggests a Momentous Move in BioMarin Pharmaceutical Stock Soon

NASDAQ: BMRN | BioMarin Pharmaceutical Inc. News, Ratings, and Charts

BMRN – A rectangle pattern has formed in the chart of BioMarin Pharmaceutical Inc. (BMRN). When this pattern is broken, a breakout or breakdown could soon occur. Read more to learn how to take advantage of this setup.

Shares of BioMarin Pharmaceutical Inc. (BMRN) have been trending sideways and a rectangle pattern has emerged. When this pattern is broken, a breakout or breakdown is expected.

BioMarin Pharmaceutical focuses on treatments for serious life-threatening medical conditions. Some of the company’s treatments include Aldurazyme to treat mucopolysaccharidosis I and Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2.

The company is seeing strong demand for Vimizim, which is used to treat Morquio syndrome. One of its newer drugs, Palynziq, is seeing strong commercial uptake in the United States and its rare disease pipeline is growing, with a focus on gene therapy agents.

BMRN had $1.1 billion in cash as of the end of the latest reported quarter, compared with no short-term debt. The company is also highly profitable with a net profit margin of 46.2%. Earnings are up 623% over the past year, but are expected to drop 122.7% in the quarter that just ended in March.

The stock has a low trailing P/E of 17.01, but a very high forward P/E of 238.10. The stock has been trending down this year, but has shown mixed recent momentum.

Take a look at the 1-year chart of BMRN below with the added notations:

Chart of BMRN provided by TradingView

Over the past year, BMRN has formed an important level to watch at the $80 (blue) mark, which has provided both support and resistance multiple times, and a key support level at $72 (green). The stock is currently sitting right between both of those levels now, setting up a trade when either key level is broken.

A long trade could be made on a break back above the $80 resistance level or a trader could enter a short position on a break below $72.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


BMRN shares were trading at $76.59 per share on Monday morning, down $0.48 (-0.62%). Year-to-date, BMRN has declined -12.66%, versus a 10.35% rise in the benchmark S&P 500 index during the same period.


About the Author: Christian Tharp


I am an expert stock market coach having helped over 4000 beginner and advanced traders & investors from around the world take control of their financial futures. I also write stock market related articles for the Adam Mesh Trading Group and Yolo Publishing. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
BMRNGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

The Fallacy of “Peak Everything”

Connected to the inflation conversation is the theory of “Peak Everything”. This idea is making its rounds through the investing world with shock waves of trading activity. Let’s talk about what it is...What it really means for the future of the S&P 500 (SPY)...And why, we will end up on the right side of action. Read on below to find out more…

:  |  News, Ratings, and Charts

Could the Fed’s Rate Reversal Lead to More Volatility in the Stock Market?

Inflation has become a recurring theme in my comments due to a notable rise in inflation metrics and how they have affected the S&P 500 (SPY). The Fed has consistently spoken of inflation being transitory over the past couple of months, which has resulted in investors becoming less concerned over higher prices. But it appeared that the Fed reversed course as it is now, indicating it would raise rates ahead of schedule. This created more volatility in the markets leading to a tough day on Friday. But, if you look closer at their remarks, not everything is as it seems. I will expand on my point below. But first, let's recap the past week in the markets. Read on below…

:  |  News, Ratings, and Charts

2nd Half of 2021 Stock Market Outlook

The stock market (SPY) has continued on a bullish path to start 2021. Yet it is not quite the same glorious bull run we enjoyed from the lows of last year. This market has become more volatile and with less upside potential. However, there is still plenty of money to be made if you look in the right places. That is the very nature of the new presentation I put together. So read on for more info…

:  |  News, Ratings, and Charts

3 Top Biotech Stocks To Bolster Your Portfolio

Illumina (ILMN), Jazz Pharmaceuticals (JAZZ), and Amgen (AMGN) are 3 of the top biotech stocks. The sector has been an underperformer over the last few years but could start outperforming given the aging population, low valuation, and growth potential.

:  |  News, Ratings, and Charts

2nd Half of 2021 Stock Market Outlook

The stock market (SPY) has continued on a bullish path to start 2021. Yet it is not quite the same glorious bull run we enjoyed from the lows of last year. This market has become more volatile and with less upside potential. However, there is still plenty of money to be made if you look in the right places. That is the very nature of the new presentation I put together. So read on for more info…

Read More Stories

More BioMarin Pharmaceutical Inc. (BMRN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BMRN News